𧬠ICD-10-CM T50.2X5A β Adverse Effect of Diuretics (Carbonic Anhydrase Inhibitors/Benzothiadiazides), Initial Encounter
Billable Code Confirmed
ICD-10-CM T50.2X5A is a valid, billable 7-character code. The structure utilizes a placeholder βXβ in the 5th position to satisfy the character requirement for the intent (5=Adverse effect) and the encounter (A=Initial).
Sequencing Rule: Manifestation First
CRITICAL CODING CONVENTION: Per ICD-10-CM Official Guidelines (Section I.C.19.e), you must code the nature of the adverse effect (the manifestation) first, followed by the code for the adverse effect of the drug (T50.2X5A). You never list this T-code as the primary or principal diagnosis.
Code Classification
ICD-10-CM Diagnosis Code β wRVU, assistant payable, and global period fields are not applicable. See CPT Procedural Crosswalk and ICD-10-PCS Crosswalk sections for associated procedural billing.
π Code Description
ICD-10-CM T50.2X5A identifies an Adverse Effect caused by diuretics including Carbonic Anhydrase Inhibitors (e.g., Acetazolamide) and Benzothiadiazides (e.g., HCTZ).
An βAdverse Effectβ occurs when a drug is correctly prescribed and properly administered, but the patient experiences a harmful reaction or side effect.^2 This code is distinct from βPoisoningβ (T50.2X1-), which involves errors in dosage, accidental ingestion, or intentional self-harm.
π³ Code Tree / Hierarchy
T50 Poisoning by, adverse effect of diuretics and other drugs... β Non-billable
β
βββ T50.2 Carbonic anhydrase inhibitors, benzothiadiazides... β Non-billable
β β
β βββ T50.2X1- Poisoning by... accidental
β βββ T50.2X2- Poisoning by... intentional self-harm
β βββ T50.2X3- Poisoning by... assault
β βββ T50.2X4- Poisoning by... undetermined
β β
β βββ T50.2X5- Adverse effect of... β Non-billable
β β βββ T50.2X5A Initial encounter β THIS CODE β
Billable
β β βββ T50.2X5D Subsequent encounter β
Billable
β β βββ T50.2X5S Sequela β
Billable
β β
β βββ T50.2X6- Underdosing of...
π Clinical Overview
Common Adverse Manifestations
Diuretics in this category commonly cause significant electrolyte and metabolic disturbances. The following conditions are frequently sequenced before T50.2X5A:
- E87.6 Hypokalemia: Thiazides (benzothiadiazides) cause significant potassium wasting in the distal tubule.
- E87.2x Metabolic Acidosis: Carbonic anhydrase inhibitors (Acetazolamide) increase bicarbonate excretion, leading to non-gap acidosis.
- E86.0 Dehydration / N17.9 Acute Kidney Injury: Over-diuresis leading to pre-renal azotemia.
- E87.1 Hyponatremia: Thiazides can cause severe low sodium, especially in elderly patients.
Specific Agents Covered
- Carbonic Anhydrase Inhibitors: Acetazolamide (Diamox), Methazolamide.
- Benzothiadiazides (Thiazides): Hydrochlorothiazide (HCTZ), Chlorthalidone, Indapamide, Metolazone.
π₯ DRG Assignment (Inpatient)
MDC 21 β Injuries, Poisonings and Toxic Effects of Drugs
| DRG | Title | Relative Weight (Approx)* |
|---|---|---|
| 917 | Poisoning & Toxic Effects of Drugs w MCC | 1.85 |
| 918 | Poisoning & Toxic Effects of Drugs w/o MCC | 1.05 |
Note: While the T-code puts the case in this MDC, the actual DRG relative weight is often influenced by the severity of the manifestation (e.g., if Hypokalemia causes a cardiac arrest).
π οΈ Commonly Associated CPT Codes (Profee)
| CPT Code | Description | wRVU | Global |
|---|---|---|---|
| 99214 | Office visit, established patient (Moderate MDM) | 1.92 | XXX |
| 80051 | Electrolyte panel | Lab | N/A |
| 80048 | Basic Metabolic Panel (BMP) | Lab | N/A |
| 99285 | Emergency Dept visit (High MDM) | 3.80 | XXX |
π Coding Scenarios and Examples
Scenario 1 β Acute Hypokalemia due to HCTZ
Clinical Vignette: A 68-year-old male presents to the clinic with profound muscle weakness. He was recently started on Hydrochlorothiazide 25mg daily for hypertension. Labs reveal a serum potassium of 2.8 mEq/L. The physician documents βHypokalemia due to HCTZ therapyβ and instructs the patient to stop HCTZ and start potassium supplements.
Correct ICD-10-CM Coding:
- E87.6 β Hypokalemia (Manifestation - Primary)
- T50.2X5A β Adverse effect of benzothiadiazides, initial encounter (Causative agent - Secondary)
- I10 β Essential (primary) hypertension (Underlying condition)
Scenario 2 β CDI Query: Adverse Effect vs. Underdosing
Clinical Vignette: Patient is admitted with volume overload. The H&P states βPatient stopped taking her HCTZ because it made her feel dizzy, now in CHF exacerbation.β
Action: The dizzy feeling when taking the drug is an Adverse Effect (T50.2X5A). The resulting volume overload because she stopped it is Underdosing (T50.2X6A).
Query: βPlease clarify if the patientβs current CHF exacerbation is considered a result of underdosing the medication due to a previous adverse effect.β
β οΈ Coding Pitfalls and Tips
| Pitfall or Tip | |
|---|---|
| β | Sequence Error. Never list T50.2X5A as the principal diagnosis. The manifestation (e.g., Acute Kidney Injury) must be first.^1 |
| β | Poisoning vs. Adverse Effect. Do not use this code if the patient accidentally took two pills instead of one. That is a poisoning (T50.2X1A). |
| β | Use the Placeholder. Always remember the βXβ in the 5th character. Without it, the code is invalid. |
| β | Capture the 7th Character. βAβ is for the initial encounter (active treatment). βDβ is for subsequent encounters (recovery phase). |
| β | Check Thiazide-like Diuretics. Note that Metolazone and Chlorthalidone are βthiazide-likeβ but are classified under this same benzothiadiazide category in ICD-10-CM. |
π Sources
1. CMS/NCHS. *ICD-10-CM Official Guidelines for Coding and Reporting, FY2026.* Section I.C.19.e: Adverse effects, poisoning, underdosing and toxic effects.2. American Society of Health-System Pharmacists (ASHP). *AHFS Drug Information: Diuretics.*
3. Ellison, D. H. (2019). Clinical Use of Diuretics. *ASPC Manual of Preventive Cardiology*. (Source for electrolyte mechanisms).
4. CMS. *2025-2026 Medicare Advantage Risk Adjustment β CMS-HCC Model v28 ICD-10-CM Mappings.*